Symbols

SIGA

SIGA Technologies·NASDAQ

--(--)

SIGA fundamentals

SIGA Q4 2025 Earnings

SIGA Technologies (SIGA) released its earnings on Mar 10, 2026: revenue was 3.80M (YoY -95.33%), beat estimates; EPS was -0.08 (YoY -112.70%), missed estimates.

Revenue / YoY

3.80M

-95.33%

EPS / YoY

-0.08

-112.70%

Report date

Mar 10, 2026

SIGA Earnings Call Summary for Q4,2025

Financial Strength: $155M cash reserve with no debt, supporting long-term growth and potential dividends.
International Momentum: $13M Asia Pacific order underscores expanding global demand for TPOXX.
Government Partnership: Ongoing U.S. engagement signals continued reliance on TPOXX for smallpox preparedness.
Pipeline Progress: Pediatric formulation Phase I underway, with PEP indication submission targeted for 2027.
EMA Update: CHMP expected to confirm smallpox treatment efficacy, excluding mpox indication.

Earnings

EPS

Revenue

Revenue & Expenses

SIGA has released its 2025 Q4 earnings report, with revenue of 3.79M, reflecting a YoY change of -95.34%, and net profit of -5.43M, showing a YoY change of -111.87%. The Sankey diagram below clearly presents SIGA's revenue sources and cost distribution.

Key Indicators

SIGA Technologies (SIGA) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

SIGA Technologies (SIGA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

SIGA Technologies (SIGA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

SIGA Technologies (SIGA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown